Syschem (India) is currently trading at Rs. 48.12, up by 0.41 points or 0.86% from its previous closing of Rs. 47.71 on the BSE.
The scrip opened at Rs. 47.01 and has touched a high and low of Rs. 49.38 and Rs. 46.85 respectively. So far 52853 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 65.10 on 23-Jan-2023 and a 52 week low of Rs. 35.15 on 19-Aug-2022.
Last one week high and low of the scrip stood at Rs. 49.85 and Rs. 45.05 respectively. The current market cap of the company is Rs. 153.07 crore.
The promoters holding in the company stood at 53.82%, while Non-Institutions held 46.18% stake in the company.
Syschem (India) has received sales order worth around Rs 1.20 crore only from Sunlovis Pharmaceuticals LLP towards Supply of Cephalexin Monohydrate (Compacted) BP; 1325 KGS and 1450 KG, 1AMOX02 Amoxicillin Trihydrate BP HSN/SAC. The said order is expected to be completed within 30 days.
Syschem (India) is a listed company engaged in the manufacture of Bulk Drugs/ Intermediates / Specialty Chemicals and contract manufacturing.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: